688166 博瑞醫藥
按盤價 
25.000 -1.190 (-4.544%) | 2023/09 - 九個月 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.394 | 12.384 | 15.688 | 12.380 | 10.666 |
| 總資產報酬率 ROA (%) | 3.984 | 6.280 | 10.170 | 10.457 | 9.674 |
| 投入資產回報率 ROIC (%) | 4.297 | 6.910 | 11.259 | 9.897 | 10.607 | 邊際利潤分析 |
| 銷售毛利率 (%) | 58.580 | 63.011 | 56.227 | 54.927 | 64.045 |
| 營業利潤率 (%) | 21.637 | 23.803 | 24.609 | 24.582 | 24.114 |
| 息稅前利潤/營業總收入 (%) | 24.255 | 24.771 | 25.009 | 24.960 | 23.268 |
| 淨利潤/營業總收入 (%) | 19.319 | 20.783 | 22.573 | 21.564 | 22.077 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 108.898 | 96.612 | 102.124 | 97.730 | 101.013 |
| 價值變動淨收益/利潤總額(%) | -4.038 | 0.232 | 3.892 | 1.877 | 2.805 |
| 營業外收支淨額/利潤總額(%) | -0.136 | 0.021 | -0.597 | -0.911 | -1.158 | 償債能力分析 |
| 流動比率 (X) | 2.147 | 2.388 | 1.703 | 3.244 | 9.815 |
| 速動比率 (X) | 1.746 | 2.043 | 1.360 | 2.548 | 8.550 |
| 資產負債率 (%) | 50.849 | 51.908 | 41.351 | 21.623 | 7.614 |
| 帶息債務/全部投入資本 (%) | 47.151 | 48.341 | 35.207 | -- | 0.879 |
| 股東權益/帶息債務 (%) | 109.097 | 105.323 | 181.201 | 584.603 | 11,272.583 |
| 股東權益/負債合計 (%) | 94.172 | 90.579 | 136.663 | 362.266 | 1,213.451 |
| 利息保障倍數 (X) | 9.165 | 25.716 | 45.853 | 41.597 | -40.815 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 94.730 | 119.636 | 94.175 | 0.000 | 113.618 |
| 存貨周轉天數 (天) | 222.693 | 229.802 | 157.568 | 0.000 | 239.005 |
| 備註： | 即時報價更新時間為 16/04/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
